Company: IMNN
Filing Date: 2025-04-04
Form Type: S-1
Source: 0001641172-25-002783
Chunk: 38

Company: Imunon, Inc.
Filing Date: 2025-04-04
Form: S-1
Chunk 38
---
|:----|:------------------------------|:----|:------------------------------------------|:----|:------|
| Offering price (1)                   |     | $                             |     | $                                         |     | $     |
| Placement Agent fees (2)             |     | $                             |     | $                                         |     | $     |
| Proceeds, before expenses, to us (3) |     | $                             |     | $                                         |     | $     |

| (1) | The                                                                                                                                        
 combined public offering price is $               per                                                                                      
 share of Common Stock and accompanying common warrant (or $                   per pre-funded warrant and accompanying common warrant).     |
| (2) | Represents                                                                                                                                 
 a cash fee equal to seven percent (7.0%) of the aggregate purchase price paid by investors in this offering. We have also agreed           
 to reimburse the Placement Agents for their accountable offering-related legal expenses in an amount up to $75,000 and for non-accountable 
 expenses of up to $20,000.                                                                                                                 |
| (3) | Does                                                                                                                                       
 not include proceeds from the exercise of the common warrants and/or pre-funded warrants in cash, if any.                                  |

Indemnification

We have agreed to indemnify the Placement Agents and other specified persons against certain liabilities, including liabilities under the Securities Act and liabilities arising from breaches of representations and warranties contained in the underwriting agreement, or to contribute to payments that the Placement Agents may be required to make in respect of those liabilities.

Lock-up Agreements

Our directors and executive officers have entered into lock-up agreements. Under these agreements, these individuals have agreed, subject to specified exceptions, not to sell or transfer any shares of Common Stock or securities convertible into, or exchangeable or exercisable for, our shares of Common Stock during a period ending 45 days after the date of this prospectus, without first obtaining the written consent of the Placement Agents. Specifically, these individuals have agreed, in part, not to:

| ● | offer,                                                                                                                                
 pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,   
 right or warrant to purchase, lend, or otherwise transfer or dispose of (or enter into any transaction or device that is designed     
 to, or could be expected to, result in the transfer or disposition by any person at any time in the future of), any shares of capital 
 stock of the Company or any securities convertible into or exercisable or exchange